Landmark study tracks hidden liver damage in genetic disorder
NCT ID NCT06512454
Summary
This study aims to learn how liver disease naturally progresses over 5 years in 500 adults with Alpha-1 antitrypsin deficiency (AATD), a genetic condition. Researchers will observe participants without giving any treatment, tracking liver scarring, lung function, and overall health through regular check-ups and questionnaires. The goal is to better understand the disease's course to help improve future care and treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALPHA1-ANTITRYPSIN DEFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Florida
RECRUITINGGainesville, Florida, 32611, United States
Contact Email: •••••@•••••
Contact
-
Universitätsklinikum Aachen AöR
RECRUITINGAachen, North Rhine-Westphalia, 52074, Germany
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.